<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Clinical syndromes of stunned or hibernating myocardium</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Clinical syndromes of stunned or hibernating myocardium</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Clinical syndromes of stunned or hibernating myocardium</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Jeroen J Bax, MD, PhD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Bernard J Gersh, MB, ChB, DPhil, FRCP, MACC</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Todd F Dardas, MD, MS</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Jun 15, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Left ventricular (LV) dysfunction, which may be an important consequence of coronary artery disease, can result from acute myocardial ischemia or myocardial infarction [<a href="#rid1">1,2</a>]. In addition, two other clinical syndromes can be associated with LV dysfunction:</p><p class="bulletIndent1"><span class="glyph">●</span>Transient postischemic dysfunction, called "stunned" myocardium</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Chronic, but potentially reversible, ischemic dysfunction, called "hibernating" myocardium</p><p></p><p>In patients with the latter disorder, LV function may improve markedly and mortality may be reduced following successful coronary revascularization. The time course of recovery is variable.</p><p>The clinical syndromes associated with stunned and hibernating myocardium and the methods used to detect stunned myocardium will be reviewed here. The pathophysiology of these disorders and the diagnosis and treatment of hibernating myocardium are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/1516.html" rel="external">"Pathophysiology of stunned or hibernating myocardium"</a> and  <a class="medical medical_review" href="/z/d/html/1474.html" rel="external">"Evaluation of hibernating myocardium"</a> and  <a class="medical medical_review" href="/z/d/html/1507.html" rel="external">"Treatment of ischemic cardiomyopathy"</a>.)</p><p class="headingAnchor" id="H2"><span class="h1">CLINICAL SYNDROMES</span><span class="headingEndMark"> — </span>Stunned myocardium follows an episode of acute coronary ischemia. In comparison, hibernating myocardium occurs in the clinical syndromes of unstable and chronic stable angina, left ventricular (LV) dysfunction, or heart failure (HF). Stunned myocardium and hibernating myocardium may also coexist in some patients. Research suggests that hibernating myocardium may occur from repetitive episodes of stunning [<a href="#rid3">3</a>].</p><p class="headingAnchor" id="H3"><span class="h2">Chronic coronary syndrome</span><span class="headingEndMark"> — </span>Support for the role of stunned or hibernating myocardium in stable angina comes from several observations:</p><p class="bulletIndent1"><span class="glyph">●</span>In patients with coronary artery disease and chronic stable angina, prolonged, but reversible LV dysfunction (stunning) occurred after a symptom-limited <a class="drug drug_general" data-topicid="9380" href="/z/d/drug information/9380.html" rel="external">dobutamine</a> infusion despite normal myocardial blood flow and myocardial oxygen consumption [<a href="#rid4">4</a>]. The degree of stunning was related to the severity of the coronary stenosis and the reduction in peak myocardial blood flow.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>LV dysfunction at rest in some patients with chronic stable angina improves after revascularization with coronary artery bypass graft surgery (CABG) or percutaneous transluminal coronary angioplasty (PTCA) [<a href="#rid5">5-12</a>]. In one PTCA study, for example, 59 of 81 (73 percent) hypokinetic or akinetic segments improved after revascularization [<a href="#rid12">12</a>]. With multivariate analysis, the best predictor of improvement in resting LV ejection fraction (LVEF) after CABG was the number of viable, asynergic myocardial segments per patient demonstrated on a resting thallium perfusion scan, that is, the number of segments that were hibernating; there was no correlation with the degree of angina [<a href="#rid5">5</a>].</p><p></p><p>Myocardial recovery may also be related to the degree of ischemia. One study using quantitative <a class="drug drug_general" data-topicid="101540" href="/z/d/drug information/101540.html" rel="external">thallium-201</a> imaging after exercise and with redistribution, showed that improvement was more likely in regions with persistent defects with a 25 to 50 percent reduction in thallium uptake compared to regions with persistent defects in which thallium uptake was reduced by &gt;50 percent (59 versus 21 percent) [<a href="#rid13">13</a>].</p><p>The reinjection of a second smaller dose of thallium immediately following the redistribution images improves the detection of stress defect reversibility [<a href="#rid14">14</a>]. This method can identify viable territories in as many as 50 to 70 percent of regions that were deemed scar by the standard three- to four-hour redistribution protocols [<a href="#rid15">15-17</a>]. The positive and negative predictive values for improvement in perfusion and wall motion are in the range of 85 percent with this technique, significantly higher than those of redistribution imaging alone. (See  <a class="medical medical_review" href="/z/d/html/1473.html" rel="external">"Assessment of myocardial viability by nuclear imaging in coronary heart disease"</a>.)</p><p>An equally accurate method for establishing hibernation is <a class="drug drug_general" data-topicid="9380" href="/z/d/drug information/9380.html" rel="external">dobutamine</a> echocardiography, which examines the inotropic or contractile reserve of dysfunctional but viable myocardium. Viable myocardium shows improved regional contractile function (inotropic reserve), as assessed by simultaneous transthoracic echocardiography, and increased metabolic activity in response to low dose dobutamine [<a href="#rid18">18</a>]. (See  <a class="medical medical_review" href="/z/d/html/1528.html" rel="external">"Dobutamine stress echocardiography in the evaluation of hibernating myocardium"</a> and  <a class="medical medical_review" href="/z/d/html/1474.html" rel="external">"Evaluation of hibernating myocardium"</a>.)</p><p class="headingAnchor" id="H4165951795"><span class="h2">Acute coronary syndromes</span></p><p class="headingAnchor" id="H4"><span class="h3">Unstable angina</span><span class="headingEndMark"> — </span>Unstable angina encompasses a variety of clinical conditions, including new onset chest pain, progressive effort angina, rest angina, and post-myocardial infarction (MI) angina. (See  <a class="medical medical_review" href="/z/d/html/43.html" rel="external">"Acute coronary syndrome: Terminology and classification"</a>.)</p><p>As described below, severe myocardial ischemia or infarction produces regional wall motion abnormalities on echocardiography or perfusion defects on perfusion imaging. Studies in which coronary occlusion occurred during percutaneous coronary intervention have shown that regional wall motion abnormalities on echocardiography occur within 10 to 30 seconds, <strong>before</strong> the onset of electrocardiographic abnormalities or chest pain  (<a class="graphic graphic_figure graphicRef79335" href="/z/d/graphic/79335.html" rel="external">figure 1</a>) [<a href="#rid19">19-21</a>].</p><p>Among patients with unstable angina, the time course of myocardial recovery after the cessation of chest pain is variable, ranging from less than two hours in patients with a short duration of chest pain (≤10 minutes) to more than 24 hours in patients with prolonged angina [<a href="#rid22">22,23</a>]. This delay in recovery, which occurs in the absence of recurrent chest pain, is thought to reflect myocardial stunning [<a href="#rid22">22,24</a>].</p><p>Hibernating myocardium also may be present, as patients with unstable angina who have not had a previous MI may have persistent reductions in perfusion and wall motion at rest [<a href="#rid23">23</a>]. Abnormal preoperative regional wall motion function is reversible with CABG in 40 percent of these patients; this improvement in wall motion is associated with an improvement of global LV function [<a href="#rid25">25</a>]. In one series, patients with unstable angina and abnormal preoperative LV function at rest had a 5- and 10-year survival after CABG that was not significantly different from that of patients with normal preoperative LV function [<a href="#rid26">26</a>].</p><p>Hibernating myocardium appears to be more common in unstable than stable angina (75 versus 28 percent in one series) [<a href="#rid27">27</a>]. The greater frequency of hibernating myocardium may explain why the 10-year survival after CABG in this study was significantly higher in patients with unstable angina and preoperative LV dysfunction than in those with stable angina and preoperative LV dysfunction; in comparison, survival in unstable and stable angina was equivalent among patients who had normal preoperative LV function.</p><p class="headingAnchor" id="H5"><span class="h3">Acute myocardial infarction</span><span class="headingEndMark"> — </span>Most patients who present with an ST segment elevation MI (STEMI) who are treated with reperfusion therapy have significant stunning with subsequent improvement in myocardial function [<a href="#rid28">28,29</a>]. This was illustrated in the US HEART study, which evaluated 249 patients with anterior STEMI in whom sequential echocardiograms were obtained [<a href="#rid28">28</a>]. At 90 days, 22 percent of those with abnormal LV function and wall motion abnormalities had complete recovery and an additional 36 percent had partial recovery; most of the improvement occurred by day 14, consistent with the concept of myocardial stunning.</p><p>Myocardial hibernation in patients with MI can occur both in the area of infarction and in a region of the LV wall at a distance from the site of infarction [<a href="#rid26">26</a>]. Support for this hypothesis comes from a report of 15 patients with single vessel coronary artery disease who were asymptomatic after an STEMI and had no clinical or exercise-induced evidence of ischemia with thallium imaging; the patients were randomly assigned to either PTCA or conservative medical therapy [<a href="#rid30">30</a>]. After a two-month follow-up, patients who underwent PTCA had improvements in coronary blood flow as measured with a Doppler flow wire, the <a class="drug drug_general" data-topicid="101540" href="/z/d/drug information/101540.html" rel="external">thallium-201</a> pathologic/normal ratio after exercise, LV wall motion, and LVEF; the patients randomized to medical therapy showed either smaller or no changes in these parameters. These data clearly demonstrate the occurrence of hibernating myocardium in the infarcted area or in an area that was presumed to be infarcted.</p><p>Hibernating myocardium after MI is associated with a high incidence of subsequent cardiac events. One report evaluated 158 patients with an MI, 57 percent of whom had hibernating myocardium as demonstrated by increased 18-fluorodeoxyglucose (FDG) uptake [<a href="#rid31">31</a>]. After a 23-month follow-up, a cardiac event (cardiac death, nonfatal MI, unstable angina, or late revascularization) occurred much more frequently in patients with evidence of hibernation (33 versus 3 percent). An increase in FDG uptake was the most significant predictor of a subsequent cardiac event, followed by the number of diseased vessels.</p><p class="headingAnchor" id="H6"><span class="h2">Severe left ventricular dysfunction or heart failure</span><span class="headingEndMark"> — </span>The importance of hibernating myocardium has been evaluated in patients with ischemic cardiomyopathy and those referred for cardiac transplantation. The prevalence of hibernating myocardium was evaluated in a meta-analysis of 24 viability studies involving 3088 patients with coronary artery disease and LV dysfunction who had a mean LVEF of 32 percent [<a href="#rid32">32</a>]. Viability was documented in 42 percent of patients. (See  <a class="medical medical_review" href="/z/d/html/1507.html" rel="external">"Treatment of ischemic cardiomyopathy"</a>.)</p><p>In addition, it has been estimated that more than 10 percent of patients referred for consideration of cardiac transplantation have an element of hibernating myocardium contributing to severe LV dysfunction [<a href="#rid33">33-35</a>]. As an example, one study of 112 cardiac transplant recipients found that severe coronary disease was found in all patients with a pretransplant diagnosis of ischemic cardiomyopathy (57 percent of the total population); it was also present in 24 percent of patients with a pretransplant diagnosis of idiopathic dilated cardiomyopathy [<a href="#rid35">35</a>].</p><p>Patients with multivessel coronary artery disease, LV dysfunction, no angina, and the lack of inducible ischemia by stress testing may also derive benefit by surgical revascularization if hibernating myocardium is present [<a href="#rid36">36</a>].</p><p>The decline in LV function that occurs with hibernating myocardium is associated with LV remodeling as manifested by increases in LV end-systolic and end-diastolic volumes and a more spherical shape of the LV [<a href="#rid37">37,38</a>]. Revascularization leads to partial reversal of these abnormalities (reverse remodeling) and an increase in LVEF [<a href="#rid37">37</a>]. The degree of improvement is significantly correlated with the number of segments that recover function after revascularization [<a href="#rid37">37</a>].</p><p>The possible benefit of revascularization with CABG or percutaneous coronary intervention in patients with coronary artery disease, LV dysfunction, and areas of hibernating myocardium is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/1507.html" rel="external">"Treatment of ischemic cardiomyopathy"</a>.)</p><p class="headingAnchor" id="H2291459959"><span class="h1">NOVEL INSIGHTS</span><span class="headingEndMark"> — </span>In many patients, chronic left ventricular (LV) dysfunction is related to a combination of hibernation, repetitive stunning, and both resting and stress-inducible ischemia. All these factors affect the likelihood of LV functional recovery. The following factors were shown to be important factors affecting success of revascularization in the PAAR-2 trial [<a href="#rid39">39</a>]: </p><p class="bulletIndent1"><span class="glyph">●</span>Extent of LV scar </p><p class="bulletIndent1"><span class="glyph">●</span>LV remodeling</p><p class="bulletIndent1"><span class="glyph">●</span>Ratio of the extent of viability versus scar </p><p></p><p>There are, however, no cut-off values for the extent of myocardial viability that is needed to result in LV functional recovery after revascularization. In addition, stabilization of LV ejection fraction (LVEF) after revascularization ("no improvement") can also be associated with improved outcomes [<a href="#rid40">40</a>]. It has also been recognized that improvement of LV function is not the only benefit of revascularization, but also improvement in diastolic dysfunction, prevention of ventricular arrhythmias, reduction in LV remodeling (dilatation, predominantly reduction in LV end-diastolic volume, but also reduction in LV end-systolic volume), and acute heart failure events may contribute to better outcomes after revascularization. </p><p>Conversely, it has been reported that when hibernation exists for longer periods of time, transition to LV fibrosis may occur, and revascularization can no longer improve LV function.</p><p>Lastly, myocardial scar but not ischemia was associated with ventricular arrythmias, appropriate implantable cardioverter-defibrillator shocks, and sudden cardiac death in patients with LVEF ≤35 percent [<a href="#rid41">41</a>].</p><p class="headingAnchor" id="H11393757"><span class="h1">UNCOMMON CAUSES</span><span class="headingEndMark"> — </span>Isolated case reports suggest that myocardial stunning may also occur following tachycardia-induced cardiomyopathy, use of cardiotoxic chemotherapy, severe hypoxia, and status epilepticus [<a href="#rid42">42-45</a>].</p><p class="headingAnchor" id="H7"><span class="h1">DETECTION OF STUNNED MYOCARDIUM</span><span class="headingEndMark"> — </span>In the setting of one of the clinical syndromes described above, noninvasive evaluation can detect myocardial stunning, although such imaging modalities are not routinely used for this purpose in clinical practice.</p><p class="headingAnchor" id="H8"><span class="h2">Echocardiography</span><span class="headingEndMark"> — </span>Myocardial ischemia produces regional wall motion abnormalities that can be detected by echocardiography within 10 to 30 seconds of acute coronary artery occlusion [<a href="#rid19">19,20</a>]. These changes occur <strong>prior</strong> to the onset of electrocardiographic changes or the development of symptoms  (<a class="graphic graphic_figure graphicRef79335" href="/z/d/graphic/79335.html" rel="external">figure 1</a>).</p><p>The time course of recovery after the cessation of chest pain is variable, ranging from less than two hours in patients with a short duration of chest pain (≤10 minutes) to more than 24 hours in patients with prolonged angina [<a href="#rid22">22</a>]. This delay in recovery, which occurs in the absence of recurrent chest pain, appears to reflect myocardial stunning [<a href="#rid22">22,24</a>]. (See  <a class="medical medical_review" href="/z/d/html/79.html" rel="external">"Role of echocardiography in acute myocardial infarction", section on 'Indications for echocardiography in MI'</a>.)</p><p class="headingAnchor" id="H9"><span class="h2">Myocardial contrast echocardiography</span><span class="headingEndMark"> — </span>Myocardial contrast echocardiography (MCE) utilizes intravenous infusion of microbubbles, which have a distinct ultrasonic density from blood or tissue and which can traverse the microvasculature, permitting visualization of myocardial perfusion. By providing simultaneous left ventricular (LV) function and perfusion information via a single modality, MCE can effectively identify dysfunctional but perfused myocardium [<a href="#rid46">46</a>].</p><p>Dysfunctional segments of the LV following an ischemic insult may represent either infarcted or "stunned" tissue. Stunned myocardium has homogeneous myocardial contrast on MCE, representing normal blood flow with an intact microvasculature, implying that reperfusion occurred prior to necrosis. In this setting, systolic function is likely to return over the next several weeks [<a href="#rid47">47-49</a>]. (See  <a class="medical medical_review" href="/z/d/html/5313.html" rel="external">"Contrast echocardiography: Clinical applications"</a>.)</p><p class="headingAnchor" id="H10"><span class="h1">DETECTION OF HIBERNATING MYOCARDIUM</span><span class="headingEndMark"> — </span>The methods used to detect hibernating myocardium are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/1474.html" rel="external">"Evaluation of hibernating myocardium"</a>.)</p><p class="headingAnchor" id="H40599841"><span class="h1">SUMMARY</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Stunned myocardium </strong>–<strong> </strong>"Stunned" myocardium is characterized as transient post-ischemic dysfunction. Stunned myocardium occurs following an episode of acute ischemia. Routine use of noninvasive tests to detect stunned myocardium is not indicated. (See <a class="local">'Clinical syndromes'</a> above and <a class="local">'Detection of stunned myocardium'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Hibernating myocardium </strong>– "Hibernating" myocardium is characterized as chronic, but potentially reversible, ischemic dysfunction. Hibernating myocardium may be seen in patients with unstable and chronic stable angina, left ventricular dysfunction, and/or heart failure. (See <a class="local">'Detection of hibernating myocardium'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Both stunned and hibernating myocardium may recover function after improvement in the ischemic insult.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Left ventricular function often improves following revascularization in patients with hibernating myocardium.</p><p></p><p class="headingAnchor" id="H2165975781"><span class="h1">ACKNOWLEDGMENT</span><span class="headingEndMark"> — </span>The UpToDate editorial staff thank Dr. David Shavelle for his past contributions to prior versions of this topic review.</p><p></p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Rahimtoola SH. The hibernating myocardium in ischaemia and congestive heart failure. Eur Heart J 1993; 14 Suppl A:22.</a></li><li><a class="nounderline abstract_t">Opie LH. The ever expanding spectrum of ischemic left ventricular dysfunction. Cardiovasc Drugs Ther 1994; 8 Suppl 2:297.</a></li><li><a class="nounderline abstract_t">Burton JO, Jefferies HJ, Selby NM, McIntyre CW. Hemodialysis-induced repetitive myocardial injury results in global and segmental reduction in systolic cardiac function. Clin J Am Soc Nephrol 2009; 4:1925.</a></li><li><a class="nounderline abstract_t">Barnes E, Hall RJ, Dutka DP, Camici PG. Absolute blood flow and oxygen consumption in stunned myocardium in patients with coronary artery disease. J Am Coll Cardiol 2002; 39:420.</a></li><li><a class="nounderline abstract_t">Ragosta M, Beller GA, Watson DD, et al. Quantitative planar rest-redistribution 201Tl imaging in detection of myocardial viability and prediction of improvement in left ventricular function after coronary bypass surgery in patients with severely depressed left ventricular function. Circulation 1993; 87:1630.</a></li><li><a class="nounderline abstract_t">Rees G, Bristow JD, Kremkau EL, et al. Influence of aortocoronary bypass surgery on left ventricular performance. N Engl J Med 1971; 284:1116.</a></li><li><a class="nounderline abstract_t">Chatterjee K, Swan HJ, Parmley WW, et al. Influence of direct myocardial revascularization on left ventricular asynergy and function in patients with coronary heart disease. With and without previous myocardial infarction. Circulation 1973; 47:276.</a></li><li><a class="nounderline abstract_t">Takeishi Y, Tono-oka I, Kubota I, et al. Functional recovery of hibernating myocardium after coronary bypass surgery: does it coincide with improvement in perfusion? Am Heart J 1991; 122:665.</a></li><li><a class="nounderline abstract_t">Marwick TH, MacIntyre WJ, Lafont A, et al. Metabolic responses of hibernating and infarcted myocardium to revascularization. A follow-up study of regional perfusion, function, and metabolism. Circulation 1992; 85:1347.</a></li><li><a class="nounderline abstract_t">Elefteriades JA, Tolis G Jr, Levi E, et al. Coronary artery bypass grafting in severe left ventricular dysfunction: excellent survival with improved ejection fraction and functional state. J Am Coll Cardiol 1993; 22:1411.</a></li><li><a class="nounderline abstract_t">Cohen M, Charney R, Hershman R, et al. Reversal of chronic ischemic myocardial dysfunction after transluminal coronary angioplasty. J Am Coll Cardiol 1988; 12:1193.</a></li><li><a class="nounderline abstract_t">van den Berg EK Jr, Popma JJ, Dehmer GJ, et al. Reversible segmental left ventricular dysfunction after coronary angioplasty. Circulation 1990; 81:1210.</a></li><li><a class="nounderline abstract_t">Gibson RS, Watson DD, Taylor GJ, et al. Prospective assessment of regional myocardial perfusion before and after coronary revascularization surgery by quantitative thallium-201 scintigraphy. J Am Coll Cardiol 1983; 1:804.</a></li><li><a class="nounderline abstract_t">Dilsizian V, Rocco TP, Freedman NM, et al. Enhanced detection of ischemic but viable myocardium by the reinjection of thallium after stress-redistribution imaging. N Engl J Med 1990; 323:141.</a></li><li><a class="nounderline abstract_t">Ohtani H, Tamaki N, Yonekura Y, et al. Value of thallium-201 reinjection after delayed SPECT imaging for predicting reversible ischemia after coronary artery bypass grafting. Am J Cardiol 1990; 66:394.</a></li><li><a class="nounderline abstract_t">Rocco TP, Dilsizian V, McKusick KA, et al. Comparison of thallium redistribution with rest "reinjection" imaging for the detection of viable myocardium. Am J Cardiol 1990; 66:158.</a></li><li><a class="nounderline abstract_t">Inglese E, Brambilla M, Dondi M, et al. Assessment of myocardial viability after thallium-201 reinjection or rest-redistribution imaging: a multicenter study. The Italian Group of Nuclear Cardiology. J Nucl Med 1995; 36:555.</a></li><li><a class="nounderline abstract_t">Sun KT, Czernin J, Krivokapich J, et al. Effects of dobutamine stimulation on myocardial blood flow, glucose metabolism, and wall motion in normal and dysfunctional myocardium. Circulation 1996; 94:3146.</a></li><li><a class="nounderline abstract_t">Hauser AM, Gangadharan V, Ramos RG, et al. Sequence of mechanical, electrocardiographic and clinical effects of repeated coronary artery occlusion in human beings: echocardiographic observations during coronary angioplasty. J Am Coll Cardiol 1985; 5:193.</a></li><li><a class="nounderline abstract_t">Wohlgelernter D, Cleman M, Highman HA, et al. Regional myocardial dysfunction during coronary angioplasty: evaluation by two-dimensional echocardiography and 12 lead electrocardiography. J Am Coll Cardiol 1986; 7:1245.</a></li><li><a class="nounderline abstract_t">Beller GA. Myocardial perfusion imaging for detection of silent myocardial ischemia. Am J Cardiol 1988; 61:22F.</a></li><li><a class="nounderline abstract_t">Jeroudi MO, Cheirif J, Habib G, Bolli R. Prolonged wall motion abnormalities after chest pain at rest in patients with unstable angina: a possible manifestation of myocardial stunning. Am Heart J 1994; 127:1241.</a></li><li><a class="nounderline abstract_t">Brown KA, Okada RD, Boucher CA, et al. Serial thallium-201 imaging at rest in patients with unstable and stable angina pectoris: relationship of myocardial perfusion at rest to presenting clinical syndrome. Am Heart J 1983; 106:70.</a></li><li><a class="nounderline abstract_t">Gerber BL, Wijns W, Vanoverschelde JL, et al. Myocardial perfusion and oxygen consumption in reperfused noninfarcted dysfunctional myocardium after unstable angina: direct evidence for myocardial stunning in humans. J Am Coll Cardiol 1999; 34:1939.</a></li><li><a class="nounderline abstract_t">Rankin JS, Newman GE, Muhlbaier LH, et al. The effects of coronary revascularization on left ventricular function in ischemic heart disease. J Thorac Cardiovasc Surg 1985; 90:818.</a></li><li><a class="nounderline abstract_t">Rahimtoola SH. The hibernating myocardium. Am Heart J 1989; 117:211.</a></li><li><a class="nounderline abstract_t">Carlson EB, Cowley MJ, Wolfgang TC, Vetrovec GW. Acute changes in global and regional rest left ventricular function after successful coronary angioplasty: comparative results in stable and unstable angina. J Am Coll Cardiol 1989; 13:1262.</a></li><li><a class="nounderline abstract_t">Solomon SD, Glynn RJ, Greaves S, et al. Recovery of ventricular function after myocardial infarction in the reperfusion era: the healing and early afterload reducing therapy study. Ann Intern Med 2001; 134:451.</a></li><li><a class="nounderline abstract_t">Sheehan FH, Doerr R, Schmidt WG, et al. Early recovery of left ventricular function after thrombolytic therapy for acute myocardial infarction: an important determinant of survival. J Am Coll Cardiol 1988; 12:289.</a></li><li><a class="nounderline abstract_t">Montalescot G, Faraggi M, Drobinski G, et al. Myocardial viability in patients with Q wave myocardial infarction and no residual ischemia. Circulation 1992; 86:47.</a></li><li><a class="nounderline abstract_t">Tamaki N, Kawamoto M, Takahashi N, et al. Prognostic value of an increase in fluorine-18 deoxyglucose uptake in patients with myocardial infarction: comparison with stress thallium imaging. J Am Coll Cardiol 1993; 22:1621.</a></li><li><a class="nounderline abstract_t">Allman KC, Shaw LJ, Hachamovitch R, Udelson JE. Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. J Am Coll Cardiol 2002; 39:1151.</a></li><li><a class="nounderline abstract_t">Luu M, Stevenson LW, Brunken RC, et al. Delayed recovery of revascularized myocardium after referral for cardiac transplantation. Am Heart J 1990; 119:668.</a></li><li><a class="nounderline abstract_t">Louie HW, Laks H, Milgalter E, et al. Ischemic cardiomyopathy. Criteria for coronary revascularization and cardiac transplantation. Circulation 1991; 84:III290.</a></li><li><a class="nounderline abstract_t">Bortman G, Sellanes M, Odell DS, et al. Discrepancy between pre- and post-transplant diagnosis of end-stage dilated cardiomyopathy. Am J Cardiol 1994; 74:921.</a></li><li><a class="nounderline abstract_t">Paolini G, Lucignani G, Zuccari M, et al. Identification and revascularization of hibernating myocardium in angina-free patients with left ventricular dysfunction. Eur J Cardiothorac Surg 1994; 8:139.</a></li><li><a class="nounderline abstract_t">Carluccio E, Biagioli P, Alunni G, et al. Patients with hibernating myocardium show altered left ventricular volumes and shape, which revert after revascularization: evidence that dyssynergy might directly induce cardiac remodeling. J Am Coll Cardiol 2006; 47:969.</a></li><li><a class="nounderline abstract_t">Rahimtoola SH, La Canna G, Ferrari R. Hibernating myocardium: another piece of the puzzle falls into place. J Am Coll Cardiol 2006; 47:978.</a></li><li><a class="nounderline abstract_t">D'Egidio G, Nichol G, Williams KA, et al. Increasing benefit from revascularization is associated with increasing amounts of myocardial hibernation: a substudy of the PARR-2 trial. JACC Cardiovasc Imaging 2009; 2:1060.</a></li><li><a class="nounderline abstract_t">Samady H, Elefteriades JA, Abbott BG, et al. Failure to improve left ventricular function after coronary revascularization for ischemic cardiomyopathy is not associated with worse outcome. Circulation 1999; 100:1298.</a></li><li><a class="nounderline abstract_t">Gupta A, Harrington M, Albert CM, et al. Myocardial Scar But Not Ischemia Is Associated With Defibrillator Shocks and Sudden Cardiac Death in Stable Patients With Reduced Left Ventricular Ejection Fraction. JACC Clin Electrophysiol 2018; 4:1200.</a></li><li><a class="nounderline abstract_t">Ishibashi K, Osamura T, Yamahara Y. Myocardial stunning with partial aneurysmal formation generated during the recovering process of tachycardia-induced cardiomyopathy. J Cardiol 2009; 54:121.</a></li><li><a class="nounderline abstract_t">Bhakta S, Flick SM, Cooney MM, et al. Myocardial stunning following combined modality combretastatin-based chemotherapy: two case reports and review of the literature. Clin Cardiol 2009; 32:E80.</a></li><li><a class="nounderline abstract_t">Shimizu M, Kagawa A, Takano T, et al. Neurogenic stunned myocardium associated with status epileptics and postictal catecholamine surge. Intern Med 2008; 47:269.</a></li><li><a class="nounderline abstract_t">Parasher PS, Daher IN. Myocardial recovery after hypoxia: stunning recovery. Echocardiography 2008; 25:1011.</a></li><li><a class="nounderline abstract_t">Rakhit DJ, Becher H, Monaghan M, et al. The clinical applications of myocardial contrast echocardiography. Eur J Echocardiogr 2007; 8:S24.</a></li><li><a class="nounderline abstract_t">Ito H, Tomooka T, Sakai N, et al. Time course of functional improvement in stunned myocardium in risk area in patients with reperfused anterior infarction. Circulation 1993; 87:355.</a></li><li><a class="nounderline abstract_t">Main ML, Magalski A, Chee NK, et al. Full-motion pulse inversion power Doppler contrast echocardiography differentiates stunning from necrosis and predicts recovery of left ventricular function after acute myocardial infarction. J Am Coll Cardiol 2001; 38:1390.</a></li><li><a class="nounderline abstract_t">Swinburn JM, Lahiri A, Senior R. Intravenous myocardial contrast echocardiography predicts recovery of dysynergic myocardium early after acute myocardial infarction. J Am Coll Cardiol 2001; 38:19.</a></li></ol></div><div id="topicVersionRevision">Topic 1527 Version 17.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8370358" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : The hibernating myocardium in ischaemia and congestive heart failure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7947371" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : The ever expanding spectrum of ischemic left ventricular dysfunction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19808220" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Hemodialysis-induced repetitive myocardial injury results in global and segmental reduction in systolic cardiac function.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11823079" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Absolute blood flow and oxygen consumption in stunned myocardium in patients with coronary artery disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8491019" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Quantitative planar rest-redistribution 201Tl imaging in detection of myocardial viability and prediction of improvement in left ventricular function after coronary bypass surgery in patients with severely depressed left ventricular function.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5553485" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Influence of aortocoronary bypass surgery on left ventricular performance.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4684928" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Influence of direct myocardial revascularization on left ventricular asynergy and function in patients with coronary heart disease. With and without previous myocardial infarction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1877443" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Functional recovery of hibernating myocardium after coronary bypass surgery: does it coincide with improvement in perfusion?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1555279" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Metabolic responses of hibernating and infarcted myocardium to revascularization. A follow-up study of regional perfusion, function, and metabolism.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8227799" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Coronary artery bypass grafting in severe left ventricular dysfunction: excellent survival with improved ejection fraction and functional state.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2971701" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Reversal of chronic ischemic myocardial dysfunction after transluminal coronary angioplasty.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2317903" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Reversible segmental left ventricular dysfunction after coronary angioplasty.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6600759" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Prospective assessment of regional myocardial perfusion before and after coronary revascularization surgery by quantitative thallium-201 scintigraphy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2362606" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Enhanced detection of ischemic but viable myocardium by the reinjection of thallium after stress-redistribution imaging.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2386113" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Value of thallium-201 reinjection after delayed SPECT imaging for predicting reversible ischemia after coronary artery bypass grafting.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2371946" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Comparison of thallium redistribution with rest "reinjection" imaging for the detection of viable myocardium.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7699441" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Assessment of myocardial viability after thallium-201 reinjection or rest-redistribution imaging: a multicenter study. The Italian Group of Nuclear Cardiology.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8989122" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Effects of dobutamine stimulation on myocardial blood flow, glucose metabolism, and wall motion in normal and dysfunctional myocardium.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3155758" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Sequence of mechanical, electrocardiographic and clinical effects of repeated coronary artery occlusion in human beings: echocardiographic observations during coronary angioplasty.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2940283" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Regional myocardial dysfunction during coronary angioplasty: evaluation by two-dimensional echocardiography and 12 lead electrocardiography.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3282420" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Myocardial perfusion imaging for detection of silent myocardial ischemia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8172052" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Prolonged wall motion abnormalities after chest pain at rest in patients with unstable angina: a possible manifestation of myocardial stunning.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6869198" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Serial thallium-201 imaging at rest in patients with unstable and stable angina pectoris: relationship of myocardial perfusion at rest to presenting clinical syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10588207" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Myocardial perfusion and oxygen consumption in reperfused noninfarcted dysfunctional myocardium after unstable angina: direct evidence for myocardial stunning in humans.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4068732" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : The effects of coronary revascularization on left ventricular function in ischemic heart disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2783527" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : The hibernating myocardium.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2522956" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Acute changes in global and regional rest left ventricular function after successful coronary angioplasty: comparative results in stable and unstable angina.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11255520" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Recovery of ventricular function after myocardial infarction in the reperfusion era: the healing and early afterload reducing therapy study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3392324" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Early recovery of left ventricular function after thrombolytic therapy for acute myocardial infarction: an important determinant of survival.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1617789" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Myocardial viability in patients with Q wave myocardial infarction and no residual ischemia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8227829" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Prognostic value of an increase in fluorine-18 deoxyglucose uptake in patients with myocardial infarction: comparison with stress thallium imaging.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11923039" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2309608" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Delayed recovery of revascularized myocardium after referral for cardiac transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1934422" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Ischemic cardiomyopathy. Criteria for coronary revascularization and cardiac transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7977122" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Discrepancy between pre- and post-transplant diagnosis of end-stage dilated cardiomyopathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8011347" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Identification and revascularization of hibernating myocardium in angina-free patients with left ventricular dysfunction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16516079" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Patients with hibernating myocardium show altered left ventricular volumes and shape, which revert after revascularization: evidence that dyssynergy might directly induce cardiac remodeling.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16516080" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Hibernating myocardium: another piece of the puzzle falls into place.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19761983" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Increasing benefit from revascularization is associated with increasing amounts of myocardial hibernation: a substudy of the PARR-2 trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10491374" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Failure to improve left ventricular function after coronary revascularization for ischemic cardiomyopathy is not associated with worse outcome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30236394" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Myocardial Scar But Not Ischemia Is Associated With Defibrillator Shocks and Sudden Cardiac Death in Stable Patients With Reduced Left Ventricular Ejection Fraction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19632531" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Myocardial stunning with partial aneurysmal formation generated during the recovering process of tachycardia-induced cardiomyopathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20014213" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Myocardial stunning following combined modality combretastatin-based chemotherapy: two case reports and review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18277028" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Neurogenic stunned myocardium associated with status epileptics and postictal catecholamine surge.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18771550" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Myocardial recovery after hypoxia: stunning recovery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17459779" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : The clinical applications of myocardial contrast echocardiography.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8425284" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Time course of functional improvement in stunned myocardium in risk area in patients with reperfused anterior infarction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11691513" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Full-motion pulse inversion power Doppler contrast echocardiography differentiates stunning from necrosis and predicts recovery of left ventricular function after acute myocardial infarction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11451273" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Intravenous myocardial contrast echocardiography predicts recovery of dysynergic myocardium early after acute myocardial infarction.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
